Correlation Between BioAffinity Technologies and Traws Pharma

Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies and Traws Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies and Traws Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between bioAffinity Technologies Warrant and Traws Pharma, you can compare the effects of market volatilities on BioAffinity Technologies and Traws Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies with a short position of Traws Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies and Traws Pharma.

Diversification Opportunities for BioAffinity Technologies and Traws Pharma

-0.41

Correlation Coefficient

BioAffinity Technologies  Traws Pharma

Very good diversification

The 3 months correlation between BioAffinity and Traws is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies Warra and Traws Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Traws Pharma and BioAffinity Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies Warrant are associated (or correlated) with Traws Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Traws Pharma has no effect on the direction of BioAffinity Technologies i.e., BioAffinity Technologies and Traws Pharma go up and down completely randomly.

Pair Corralation between BioAffinity Technologies and Traws Pharma

Assuming the 90 days horizon bioAffinity Technologies Warrant is expected to under-perform the Traws Pharma. But the stock apears to be less risky and, when comparing its historical volatility, bioAffinity Technologies Warrant is 2.48 times less risky than Traws Pharma. The stock trades about -0.15 of its potential returns per unit of risk. The Traws Pharma is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  518.00  in Traws Pharma on October 4, 2024 and sell it today you would earn a total of  349.00  from holding Traws Pharma or generate 67.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	66.67%
Values	Daily Returns

bioAffinity Technologies Warra  vs.  Traws Pharma

BioAffinity Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days bioAffinity Technologies Warrant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Traws Pharma

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Traws Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Traws Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BioAffinity Technologies and Traws Pharma

The main advantage of trading using opposite BioAffinity Technologies and Traws Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies position performs unexpectedly, Traws Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will offset losses from the drop in Traws Pharma's long position.

The idea behind bioAffinity Technologies Warrant and Traws Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.